TC BioPharm (TCBP) announced that shareholders have formally approved the recently announced 25% stock dividend. TC BioPharm declared that last week’s proposed special stock dividend was formally approved at today’s General Meeting of the Company. The special dividend of 0.25 American Depositary Shares for every 1 ADS held by shareholders on the record date of January 2, 2025 are expected to be delivered to shareholders on or about January 6th. Per Nasdaq requirements, trading in the Company’s ADSs will temporarily stop at 5:00 pm on January 2, 2025, and recommence on or around January 8, 2025, to allow the Depositary to process the stock dividend. Nasdaq will adjust the opening price on January 8 to reflect the dilution impact of the stock dividend.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TCBP:
- TC Biopharm advances ACHIEVE Phase 2b clinical trial
- TC BioPharm Advances Strategic Financial Initiative with New ADS Offering
- TC BioPharm Announces Key Shareholder Meeting
- TC Biopharm announces partnership with CareDx
- TC Biopharm price target lowered to $3 from $7 at H.C. Wainwright
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
